eISSN: 1897-4252
ISSN: 1731-5530
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2006
vol. 3
 
Share:
Share:
abstract:

Torakochirurgia
Malignant pleural mesothelioma – the progress in combined management

Maciej Krzakowski

Kardiochir Torakochir Pol 2006; 3, 1: 59-63
Online publish date: 2006/05/19
View full text Get citation
 
Malignant pleural mesothelioma has a very unfavourable prognosis due to the frequently advanced stage of disease. Histologically, there are 3 types of disease (epithelioid, sarcomatoid, and mixed) with different prognoses. Immunohistochemistry is essential to precisely diagnose and to differentiate malignant pleural mesothelioma from malignancies. Chest computed tomography is the primary imaging modality, whereas magnetic resonance imaging is used for final preoperative assessment. The current TNM staging system is based on the extent of local and lymph node involvement. Curative resections are performed in less than 10% of patients with unclear indications for radical interventions. The use of conventional radiotherapy is limited due to the risk of radiation-induced complications. Platinum compounds, doxorubicin, and several antifolates show modest activity in advanced disease. Given the natural course of malignant pleural mesothelioma and the relatively low effectiveness of single treatments, the multidisciplinary approach is promising. However, a combined approach should be provided in experienced institutions.
keywords:

malignant pleural mesothelioma, treatment, multidisciplinary approach

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.